After over a 100 million cases and 2 million deaths, the global effort to vaccinate the world against COVID-19 began in early December last year. Although more than 40 countries started administering COVID-19 vaccines to their people, few stood apart in terms of their vaccination rates while others faltered despite having all the resources.
Drug makers are finding themselves in an inevitable position. Since the start of the coronavirus crisis, share prices have soared and public criticism has grown muted. However an elaborate cover-up is underway to hide a sordid past.
A well-renowned infectious disease expert from the University of Minnesota has warned that the novel Coronavirus disease can potentially spread to 70% of the population without an effective vaccine before it reaches global herd immunity.
Does smoking better adapt the human lungs to fight Covid-19? Not quite. But nicotine is under the microscope as a possible preventive measure against the need for hospitalization. Moreover, will nicotine in tea instead of tobacco have the same impact that prevents Covid-19 causing an immune overreaction?